Citation Impact
Citing Papers
A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia
2013
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease
2014
UK guidelines on the management of iron deficiency in pregnancy
2012
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
2016 StandoutNobel
The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review
2003
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
2016 StandoutNobel
Restless Legs Syndrome
2008
Central Sleep Apnea and Cheyne-Stokes Respiration
2008
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Double-Blind Comparison of Full and Partial Anemia Correction in Incident Hemodialysis Patients without Symptomatic Heart Disease
2005
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD
2005
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
2007
Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agents
2010
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Advances in glomerular filtration rate-estimating equations
2010
Darbepoetin alfa Administered Every Other Week Maintains Hemoglobin Levels over 52 Weeks in Patients with Chronic Kidney Disease Converting from Once-Weekly Recombinant Human Erythropoietin: Results from Simplify the Treatment of Anemia with Aranesp (STAAR)
2006
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis
2007
Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
2006
Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa
2006
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
2014
Chronic kidney disease
2011 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Hemoglobin Targets for the Anemia of Chronic Kidney Disease
2004
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
2008
Calcimimetics: a remedy for all problems of excess parathyroid hormone activity in chronic kidney disease?
2005
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk
2006
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
2006
Cardiorenal Syndrome
2008 Standout
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology
2017 Standout
FIND-CKD: intravenous iron in predialysis CKD
2014
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Guideline for the laboratory diagnosis of functional iron deficiency
2013
Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients
2016
Sex, haemoglobin and kidney disease: new perspectives
2005
The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation
2007
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
2006
Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series
2014
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
2005
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
2014
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
2005
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
2015
Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis
2004
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
2014
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
2013
Potential adverse effects of proton pump inhibitors
2008
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Antioxidants: A Possible Role in Kidney Protection
2003
Lipid oxidation and improving the oxidative stability
2010 Standout
Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study
2006
Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
2009
Chronic Kidney Disease
2016 Standout
Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure
1995
Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
2009
Anemia of Chronic Disease
2005 Standout
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
2019
Treatment of anemia in the diabetic patient with retinopathy and kidney disease
2003
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
2011
Neuroprotective Effect of Darbepoetin Alfa, a Novel Recombinant Erythropoietic Protein, in Focal Cerebral Ischemia in Rats
2005
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
2014
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
2012
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
2008
Daily iron supplementation for improving anaemia, iron status and health in menstruating women
2016
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease
2010
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
2006
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
2020 Standout
A Critical Appraisal of the Quality of Quality-of-Life Measurements
1994 Standout
Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice.
1991 StandoutNobel
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
Pathophysiology of Sleep Apnea
2010 Standout
Poly(ADP-ribose) (PAR) polymer is a death signal
2006 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Iron-Deficiency Anemia
2015 Standout
Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
2014
Diabetic Autonomic Neuropathy
2003 Standout
Vascular Calcification
2006 Standout
Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.
1991 StandoutNobel
Polycythemia in transgenic mice expressing the human erythropoietin gene.
1989 StandoutNobel
Anemia in Chronic Heart Failure
2006
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Treatment of Anemia in Patients With Heart Disease
2013
Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
2016
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of Simon D. Roger being referenced
Contribution of anaemia to progression of renal disease: a debate
2002
Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease
2008
Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis
2005
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study
2011
Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis
1991
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
2010
Effects of Early and Late Intervention with Epoetin α on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4)
2004
What is the practical conversion dose when changing from epoetin alfa to darbepoetin outside of clinical trials?
2004
Darbepoetin Alfa Effectively Treats Anemia in Patients with Chronic Kidney Disease with de novo Every-Other-Week Administration
2004
Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease
2004
C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
2011
Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights
2012
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
2014
Proton Pump Inhibitors and Acute Interstitial Nephritis
2006
Sodium Zirconium Cyclosilicate in Hyperkalemia
2014
Rabeprazole‐induced acute interstitial nephritis
2005
Effect of Early Correction of Anemia on the Progression of CKD
2006
Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure
2006
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
2014
Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
1993
Effects of erythropoietin on blood pressure.
1991
Diagnosis and management of iron deficiency anaemia: a clinical update
2010
Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?
2002